{
    "clinical_study": {
        "@rank": "112639", 
        "arm_group": {
            "arm_group_label": "Aerosolized Vancomycin", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether aerosolized vancomycin is effective in the\n      treatment of methicillin-resistant staphylococcus aureus pneumonia under mechanical\n      ventilation."
        }, 
        "brief_title": "Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation", 
        "condition": [
            "Pneumonia, Staphylococcal", 
            "Methicillin-Resistant Staphylococcus Aureus"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia", 
                "Pneumonia, Staphylococcal", 
                "Staphylococcal Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Nosocomial or severe community-acquired pneumonia due to Methicillin-Resistant\n             Staphylococcus aureus\n\n          -  Must be mechanically ventilated in intensive care unit\n\n        Exclusion Criteria:\n\n          -  Non-bacterial pneumonia, such as viral, fungal, tuberculosis infections\n\n          -  Underlying respiratory condition: bronchiectasis, post-tuberculosis, chronic\n             obstructive pulmonary disease or asthma\n\n          -  Complicated pneumonia, such as empyema, parapneumonic effusion requiring chest tube\n             or drainage\n\n          -  Already or previous treated with intravenous vancomycin (Not pneumonia)\n\n          -  Adverse reaction due to inhaled ventolin before treatment of aerosolized vancomycin\n\n          -  Hypersensitivity of vancomycin or glycopeptide antibiotics\n\n          -  Positive culture of Enterococcus in respiratory specimen\n\n          -  Pregnant or Breast-feeding patient\n\n          -  Immunocompromised hosts: more than 1mg/kg of corticosteroid users for more than 3\n             months, transplantation recipients, AIDS patients\n\n          -  Another aerosolized antibiotics within 48 hours of study enrollment\n\n          -  Not adherent to mechanical ventilation protocol of this study\n\n          -  Not arterial line monitoring\n\n          -  Vancomycin minimum inhibitory concentration >= 2\u338d/\u3396 of cultured Staphylococcus aureus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925066", 
            "org_study_id": "B-1206-156-004"
        }, 
        "intervention": {
            "arm_group_label": "Aerosolized Vancomycin", 
            "intervention_name": "Vancomycin", 
            "intervention_type": "Drug", 
            "other_name": "250mg bid, Inhalation for 5-7 days"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Methicillin", 
                "Vancomycin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2014", 
        "link": {
            "description": "Optimal Two-Stage Designs For Phase II Clinical Trials", 
            "url": "http://linus.nci.nih.gov/brb/samplesize/otsd.html"
        }, 
        "location": {
            "contact": {
                "email": "lungdrcho@gmail.com", 
                "last_name": "Young-Jae Cho, MD", 
                "phone": "+82-31-787-7058"
            }, 
            "facility": {
                "address": {
                    "city": "Seongnam", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }, 
            "investigator": {
                "last_name": "Young-Jae Cho, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Optimal Two-Stage Phase 2 Study of Efficacy and Pharmacokinetics of Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation", 
        "other_outcome": {
            "measure": "microbiological response", 
            "safety_issue": "No", 
            "time_frame": "within the first 30 days after treatment"
        }, 
        "overall_contact": {
            "email": "lungdrcho@gmail.com", 
            "last_name": "Young-Jae Cho, MD", 
            "phone": "+82-31-787-7058"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Jae-Joon Yim, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "clinical cure rate", 
            "safety_issue": "No", 
            "time_frame": "within the first 30 days after treatment"
        }, 
        "reference": {
            "PMID": "2702835", 
            "citation": "Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989 Mar;10(1):1-10."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925066"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "the peak level of serum vancomycin level", 
            "safety_issue": "No", 
            "time_frame": "on 3rd and 5th days after treatment"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}